Inovio Pharmaceuticals Inc vs Shell PLC — how do they compare? Inovio Pharmaceuticals Inc trades at $1.08 (market cap $89.27M), while Shell PLC trades at $86.69 (market cap $235.24B). The key difference: Shell PLC is far larger — about 2635.2× Inovio Pharmaceuticals Inc's market cap, and Shell PLC pays a 3.63% dividend while Inovio Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| INO | SHEL | |
|---|---|---|
Market Cap | $89.27M | $235.24B |
Sector | Health | Energy |
52-Week High | $2.87 | $94.15 |
52-Week Low | $1.05 | $70.31 |
Enterprise Value | $60.28M | $287.77B |
Dividend Yield | — | 3.63% |
Trailing returns across standard periods
Latest headlines on both assets
Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
Read more on INO →Shell is an integrated oil and gas company that explores for, produces, and refines oil around the world. In 2021, it produced 1.7 million barrels of liquids and 8.7 billion cubic feet of natural gas per day. At year-end 2021, reserves stood at 9.2 billion barrels of oil equivalent, 50% of which consisted of liquids. Its production and reserves are in Europe, Asia, Oceania, Africa, and North and South America. The company operates refineries with capacity of 1.8 mmb/d located in the Americas, Asia, Africa, and Europe and sells 15 mtpa of chemicals. Its largest chemical plants, often integrated with its local refineries, are in Central Europe, China, Singapore, and North America.
Read more on SHEL →